ITMI20030317A1 - COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT. - Google Patents

COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.

Info

Publication number
ITMI20030317A1
ITMI20030317A1 IT000317A ITMI20030317A ITMI20030317A1 IT MI20030317 A1 ITMI20030317 A1 IT MI20030317A1 IT 000317 A IT000317 A IT 000317A IT MI20030317 A ITMI20030317 A IT MI20030317A IT MI20030317 A1 ITMI20030317 A1 IT MI20030317A1
Authority
IT
Italy
Prior art keywords
indolopirrolocarbazolo
derivative
cancer agent
another anti
combined therapy
Prior art date
Application number
IT000317A
Other languages
Italian (it)
Inventor
Marina Ciomei
Enrico Pesenti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Priority to IT000317A priority Critical patent/ITMI20030317A1/en
Priority to EP04711372A priority patent/EP1599210A1/en
Priority to BRPI0407642-7A priority patent/BRPI0407642A/en
Priority to PCT/EP2004/050130 priority patent/WO2004073719A1/en
Priority to JP2006502025A priority patent/JP2006518355A/en
Priority to CA002516097A priority patent/CA2516097A1/en
Priority to MXPA05008879A priority patent/MXPA05008879A/en
Priority to TW093103888A priority patent/TW200500073A/en
Priority to ARP040100529A priority patent/AR043241A1/en
Priority to CL200400319A priority patent/CL2004000319A1/en
Publication of ITMI20030317A1 publication Critical patent/ITMI20030317A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IT000317A 2003-02-21 2003-02-21 COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT. ITMI20030317A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (en) 2003-02-21 2003-02-21 COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.
EP04711372A EP1599210A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
BRPI0407642-7A BRPI0407642A (en) 2003-02-21 2004-02-16 combination therapy comprising an indole pyrrol carbazole derivative and another antitumor agent
PCT/EP2004/050130 WO2004073719A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
JP2006502025A JP2006518355A (en) 2003-02-21 2004-02-16 Combination therapy including indolopyrrolocarbazole derivatives and other antitumor agents
CA002516097A CA2516097A1 (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
MXPA05008879A MXPA05008879A (en) 2003-02-21 2004-02-16 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent.
TW093103888A TW200500073A (en) 2003-02-21 2004-02-18 Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
ARP040100529A AR043241A1 (en) 2003-02-21 2004-02-20 COMBINED THERAPY THAT INCLUDES AN INDOLPIRROL-CARBAZOL DERIVATIVE AND ANOTHER ANTITUMORAL AGENT
CL200400319A CL2004000319A1 (en) 2003-02-21 2004-02-20 PHARMACEUTICAL COMBINATION THAT INCLUDES EDOTECARINE OR A PHARMACEUTICALLY ACCEPTABLE SALT AND DOCETAXEL OR CAPACITABINE, THERAPEUTIC KIT, USEFUL FOR THE TREATMENT OF CANCER.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (en) 2003-02-21 2003-02-21 COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.

Publications (1)

Publication Number Publication Date
ITMI20030317A1 true ITMI20030317A1 (en) 2004-08-22

Family

ID=32894164

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000317A ITMI20030317A1 (en) 2003-02-21 2003-02-21 COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.

Country Status (10)

Country Link
EP (1) EP1599210A1 (en)
JP (1) JP2006518355A (en)
AR (1) AR043241A1 (en)
BR (1) BRPI0407642A (en)
CA (1) CA2516097A1 (en)
CL (1) CL2004000319A1 (en)
IT (1) ITMI20030317A1 (en)
MX (1) MXPA05008879A (en)
TW (1) TW200500073A (en)
WO (1) WO2004073719A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2500465T3 (en) * 2006-10-06 2014-09-30 Bavarian Nordic Inc. Recombinant modified Ankara vaccinia virus encoding HER-2 antigen in combination with a taxane for use in cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
CA2401191C (en) * 2000-02-28 2006-05-02 Aventis Pharma S.A. A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer

Also Published As

Publication number Publication date
JP2006518355A (en) 2006-08-10
MXPA05008879A (en) 2005-10-05
BRPI0407642A (en) 2006-03-01
CL2004000319A1 (en) 2005-04-22
TW200500073A (en) 2005-01-01
CA2516097A1 (en) 2004-09-02
EP1599210A1 (en) 2005-11-30
WO2004073719A1 (en) 2004-09-02
AR043241A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
EE200500035A (en) Personal therapy section
EE200500011A (en) Indazoles, benzothiazoles and benzoisothiazoles, their preparation and use
IL173398A0 (en) Pyridyl derivatives and their use as therapeutic agents
DE60324099D1 (en) DRUG-CONTAINING TAMPON
NO20053817D0 (en) Preparations and Methods for Antiviral Combination Therapy.
FR2854158B1 (en) 2-ACYLAMINO-4-PHENYLETHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2866884B1 (en) ARYL-AND HETEROARYL-PIPERIDINECARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2864080B1 (en) 1-PIPERAZINE-AND-1-HOMOPIPERAZINE-CARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2854633B1 (en) PIPERIDINYL-AND PIPERAZINYL-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2850377B1 (en) ARYLALKYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
MA27233A1 (en) PIPERAZINYLACYLPIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO20050689L (en) Therapeutic use
NL1033403A1 (en) Therapeutic pyrazolo [3,4-b] pyridines and indazoles.
DK1556382T3 (en) 3-Phenylpyridoindole derivatives, preparation and therapeutic use thereof
ITRM20030363A0 (en) COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.
ZA200210316B (en) Composition and its therapeutic use.
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2873693B1 (en) AMINO-TROPANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE112004001618D2 (en) Pharmaceutical agent against tumor diseases
ITMI20030317A1 (en) COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.
NO20053189D0 (en) HVC-combination therapy.
FR2842527B1 (en) ACYLOXYPYROLIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2866886B1 (en) ARYL-AND HETEROARYL-AKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2850969B1 (en) ACYLATED AMINOPROPANEDIOLS AND THE LIKE AND THEIR THERAPEUTIC USES